Patient and Caregiver Priorities in Neuro-oncology Care
NCT ID: NCT06676306
Last Updated: 2025-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2024-04-24
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychological Intervention For Brain Tumor Caregivers
NCT04109209
Phase I/II Cancer Caregiver Interventions to Improve Quality of Life and Prevent Burnout
NCT02166866
Improving Communication in Older Cancer Patients and Their Caregivers
NCT02107443
An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer
NCT03069105
Experience of Brain Tumor Caregivers
NCT00352820
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Describe the patient experience and characterize the symptom burden related to primary or metastatic central nervous system tumors.
II. Describe the caregiver experience and caregiver needs related to patients with primary or metastatic central nervous system tumors. III. Establish which interventional treatment outcomes are important to patients and caregivers, within a wider understanding of their lived experience with CNS tumors and their treatment.
OUTLINE: This is an observational study.
Patients and their caregivers participate in interviews on study. Patients also have their medical records reviewed on study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational
Patients and their caregivers participate in interviews on study. Patients also have their medical records reviewed on study.
Non-Interventional Study
Non-Interventional Study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Interventional Study
Non-Interventional Study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of primary or metastatic CNS tumor with a primary caregiver, should patient wish to involve one.
* Willing and able to participate in a semi-structured interview lasting approximately 60 minutes. Dyad interviews conducted for participants who elect to involve a caregiver.
* Willing and able to participate in a single follow-up interview. Dyad follow up interviews conducted for participants who elect to involve a caregiver.
Exclusion Criteria
* Vulnerable populations: pregnant or nursing persons, prisoners, or persons lacking capacity for understanding.
* Unable to read and speak English.
* Note: English does not need to be primary language.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ugur T. Sener, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-09052
Identifier Type: REGISTRY
Identifier Source: secondary_id
24-000229
Identifier Type: OTHER
Identifier Source: secondary_id
24-000229
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.